Benign neoplasm: Connective and other soft tissue of abdomen

CD2_BENIGN_CONNSOFT_ABD

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D21.4& Hospital discharge: ICD-9 — 2155 Cause of death: ICD-10 — D21.4& Cause of death: ICD-9 — 2155 2 out of 7 registries used, show all original rules.	102
4. Check minimum number of events None	102
5. Include endpoints None	102
6. Filter based on genotype QC (FinnGen only)	93

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D21
Name in latin: Neoplasma benignum textus connectivi abdominis

NAME	CD2_BENIGN_CONNSOFT_ABD
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D214
HD_ICD_9	2155
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D214
COD_ICD_9	2155
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Connective and other soft tissue of abdomen based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	814	549	263
Only index persons	728	504	224
Unadjusted period prevalence (%)
Whole population	0.01	0.02	0.01
Only index persons	0.02	0.02	0.01
Median age at first event (years)
Whole population	46.06	43.94	50.31
Only index persons	44.26	42.22	48.84

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	93	65	28
Unadjusted period prevalence (%)	0.02	0.02	0.01
Median age at first event (years)	47.67	42.85	58.86

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
102: Matched controls
1020

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D21.4

ICD-10 Finland

Benign neoplasm: Connective and other soft tissue of abdomen

3495.7

101.6

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

11.0

22.5

JAA10

NOMESCO Finland

Excision of lesion of abdominal wall

+∞

10.6

9736

FHL

Subcutaneous tumor removal in operating room or anesthesia

20.3

7.8

2155X

ICD-9 Finland

Other benign neoplasm of connective and other soft tissue, Abdomen[ABDOMENIN BENIGNI PEHMYTKUDOSKASVAIN,TARK MÄÄRITTEL]

+∞

7.4

2155A

ICD-9 Finland

Other benign neoplasm of connective and other soft tissue, Abdomen[ABDOMENIN BENIGNI PEHMYTKUDOSKASVAIN,SIDEKUDOSPERÄI]

+∞

6.3

6141

FHL

Exploration or removal of a local change in the abdominal wall (umbilical cord, tumor, hematoma, endometrioma)

+∞

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

146

2.74

4.87

3.9

3.0

91.72

73.64

ng/l

0.12

107

(3013707) Erythrocyte sedimentation rate by Westergren method

627

2.42

3.29

3.7

4.2

14.08

11.26

mm/h

0.85

574

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.55

3.23

1.7

1.6

—

(3018418) pH of Serum or Plasma

248

2.09

3.14

2.9

4.0

7.39

7.40

—

(3000991) Gas panel - Venous blood

2.81

2.94

9.8

7.1

—

(3002256) Pathology report gross observation

2.40

2.77

1.2

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

850

3.20

2.59

20.2

13.1

23.86

20.84

mg/l

0.37

663

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

134

2.15

2.56

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.34

2.52

1.7

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

276

1.89

2.43

3.2

2.0

—

(3023368) Bacteria identified in Blood by Culture

197

1.91

2.23

6.3

3.9

—

(3042936) Bacteria identified in Isolate by Culture

111

2.12

2.21

3.2

1.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

392

1.73

1.98

8.2

6.7

1.21

1.22

mmol/l

0.50

332

(3000492) Spirometry study

2.38

1.93

1.5

1.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

600

1.76

1.78

4.1

4.3

—

(3002582) Erythrocytes [#/volume] in Urine

247

1.71

3.4

3.0

31.73

291.84

e6/l

0.49

189

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2.16

1.68

12.7

8.2

123.64

121.29

g/l

0.12

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

367

1.65

1.66

6.9

5.6

1.21

1.22

mmol/l

0.12

337

(40768804) Tissue Pathology biopsy report

349

1.64

1.65

2.3

2.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

174

1.75

1.59

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

428

1.62

1.58

4.1

3.7

0.00

estimate

—

(3020682) Albumin/Creatinine [Ratio] in Urine

235

1.67

1.56

2.9

3.6

13.71

8.90

mg/mmol

0.15

151

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

209

1.69

1.55

3.4

1.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

884

2.46

1.54

23.6

15.4

74.42

73.84

umol/l

0.09

884

(3030467) Casts [#/volume] in Urine by Automated count

219

1.67

1.52

3.6

2.8

0.50

0.38

e6/l

0.18

159

(3021601) Nitrite [Presence] in Urine by Test strip

423

1.59

1.48

6.0

4.9

0.00

estimate

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

553

1.62

1.47

3.2

3.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.90

1.46

18.0

6.5

104.06

103.69

mmol/l

0.12

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

2.83

1.45

1.7

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

2.83

1.45

1.7

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

196

1.67

1.43

3.4

3.3

—

(3015736) pH of Urine

341

1.57

1.40

3.9

3.3

5.50

5.75

—

(3044889) 12 lead EKG panel

577

1.61

1.40

3.7

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.25

1.39

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.25

1.38

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.88

1.34

1.5

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

2.59

1.32

1.3

1.2

—

(3019150) Specific gravity of Urine by Refractometry

192

1.63

1.30

3.8

3.5

1.02

kg/l

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

125

1.75

1.30

2.9

2.5

2.22

2.99

e6/l

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

501

1.54

1.30

9.0

4.28

4.21

e9/l

0.06

444

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

150

1.69

1.29

1.2

1.3

0.97

8.75

u/ml

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

413

1.53

1.29

3.5

2.4

—

(36304419) Bacteria [Presence] in Urine

219

1.60

1.28

3.5

2.8

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.48

1.26

1.0

1.3

—

(3018095) Leukocytes [#/volume] in Urine

293

1.54

1.23

4.1

3.5

185.29

59.04

e6/l

0.63

204

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

284

1.54

1.23

3.6

2.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

204

1.59

1.21

1.9

2.6

355.30

6234.18

umol/l

1.06

174

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.08

1.15

1.4

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

155

1.62

1.14

1.1

1.3

10.83

29.94

iu/ml

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

775

1.70

1.12

4.2

3.9

1.33

1.29

mmol/l

0.19

704

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1.78

1.11

3.1

4.1

283.00

234.89

u/l

0.54

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2.20

1.08

1.4

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.20

1.08

7.3

6.8

22.13

26.31

mmol/l

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

133

1.63

1.04

2.9

2.3

0.67

1.34

e6/l

—

(40768797) Stomach Pathology biopsy report

125

1.64

1.03

1.3

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

428

1.44

1.01

4.2

3.6

0.00

estimate

—

(3037121) Protein [Mass/volume] in Urine

0.00

0.99

0.0

3.6

—

0.14

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.99

0.0

2.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.99

0.0

1.3

—

(3012516) Albumin [Mass/volume] in Urine

223

1.49

0.97

2.7

3.1

80.66

68.69

mg/l

0.06

147

(3000494) Fungus identified in Specimen by Culture

103

1.66

0.94

1.4

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

774

1.59

0.93

6.1

5.4

40.28

39.42

mmol/mol

0.36

726

(3019198) Lymphocytes [#/volume] in Blood

442

1.41

0.93

5.8

5.5

2.05

1.98

e9/l

0.07

399

(3013115) Eosinophils [#/volume] in Blood

443

1.41

0.92

6.1

5.7

0.18

e9/l

0.03

397

(40758558) Short blood count panel - Blood

217

1.47

0.91

6.5

7.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2.13

0.91

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

821

1.66

0.90

4.5

4.3

4.54

4.70

mmol/l

0.88

761

(3021589) Normoblasts [#/volume] in Blood

357

1.41

0.90

8.7

9.1

0.00

e9/l

0.50

286

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

834

1.67

0.87

5.0

4.8

2.63

2.77

mmol/l

0.89

768

(3001604) Monocytes [#/volume] in Blood

428

1.38

0.84

6.0

5.4

0.63

0.59

e9/l

0.48

377

(3006315) Basophils [#/volume] in Blood

428

1.38

0.84

5.9

5.5

0.04

e9/l

0.07

377

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

134

1.51

0.78

6.2

4.9

23.81

20.66

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1.76

0.78

1.6

1.5

1.25

1.27

g/l

—

(3029937) Albumin [Presence] in Urine by Test strip

233

1.41

0.77

3.7

3.8

0.00

estimate

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

806

1.54

0.77

4.5

5.86

5.87

mmol/l

0.02

744

(40761511) CBC panel - Blood by Automated count

878

1.67

0.76

17.4

12.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1.90

0.75

2.7

2.5

0.61

0.72

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1.90

0.75

20.7

7.8

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

574

1.37

0.75

3.3

3.0

66.97

47.94

u/l

0.94

539

(3009214) Lutropin [Units/volume] in Serum or Plasma

2.05

0.74

1.4

1.2

18.30

10.87

u/l

—

(3037522) Nuclear Ab [Titer] in Serum

119

1.51

0.73

1.3

1.5

176.00

394.07

titre

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1.76

0.71

2.7

2.5

0.96

1.12

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

155

1.45

0.70

1.8

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

174

1.42

0.68

1.9

2.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1.63

0.66

2.7

3.5

127.71

129.64

g/l

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

334

1.33

0.65

4.6

3.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1.70

0.62

2.2

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

159

1.40

0.62

1.2

1.4

—

(3019060) Gas panel - Arterial blood

1.58

0.61

1.8

4.9

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.61

0.0

1.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1.50

0.60

1.8

2.9

9.71

7.61

umol/l

0.20

(3003694) ABO and Rh group [Type] in Blood

247

0.72

0.60

1.7

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

931

1.85

0.59

30.1

19.9

38.69

39.94

0.80

880

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1.58

0.57

3.6

2.1

5.07

5.00

ug/l

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.58

0.57

4.7

4.4

4.43

4.74

pmol/l

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1.66

0.56

3.8

3.4

38.90

46.08

—

(40760892) CBC W Ordered Manual Differential panel - Blood

398

1.28

0.56

6.0

5.9

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1.57

0.54

3.5

3.7

25.35

24.88

mmol/l

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1.50

0.50

2.5

2.2

0.21

0.22

g/l

0.24

(4035726) Immunohistochemistry procedure

1.50

0.50

1.5

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

335

1.27

0.49

2.2

2.0

78.45

97.33

pmol/l

0.84

171

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.47

0.49

1.3

2.2

342.42

359.43

nmol/l

0.10

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

802

1.36

0.49

19.8

12.3

82.92

82.87

ml/min/173m2

0.01

634

(3022217) INR in Platelet poor plasma by Coagulation assay

378

1.24

0.44

18.7

12.6

1.33

1.16

inr

0.41

115

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.64

0.43

1.0

1.2

—

(3025941) Bacteria identified in Stool by Culture

1.41

0.43

1.0

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

101

0.67

0.42

1.6

2.1

—

(3026008) Bacteria identified in Urine by Culture

245

1.26

0.41

3.3

2.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.41

0.0

1.9

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.41

0.0

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.41

0.0

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.40

0.0

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.39

0.0

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.39

0.0

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.39

0.0

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.39

0.0

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.39

0.0

1.3

—

(40761535) Cells panel - Urine sediment

1.33

0.38

4.4

3.1

—

(40761536) Microorganisms panel - Urine sediment

1.31

0.38

2.7

4.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

279

1.21

0.34

2.8

2.5

63.89

54.07

u/l

0.76

257

(3015377) Calcium [Moles/volume] in Serum or Plasma

289

1.21

0.34

3.9

3.7

2.36

mmol/l

0.04

253

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.32

0.31

1.1

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

206

1.22

0.30

1.5

1.2

0.74

0.81

u/ml

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

104

1.29

0.28

10.0

8.5

—

(40768443) Skin Pathology biopsy report

1.37

0.24

1.2

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

209

0.83

0.24

1.8

1.4

18.73

21.47

nmol/l

0.47

172

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.72

0.23

1.7

1.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

107

1.25

0.23

1.5

1.8

—

(3000330) Specific gravity of Urine by Test strip

1.20

0.22

6.0

3.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.21

0.0

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.5

—

(3005570) Glucose [Moles/volume] in Urine

0.00

0.21

0.0

2.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.21

0.0

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

2.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

108

1.23

0.21

2.2

1.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

1.33

—

(40768795) Lymph node Pathology biopsy report

0.00

0.21

0.0

1.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.4

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.21

0.0

5.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

113

0.78

0.21

1.7

2.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

2.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.20

0.0

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.16

0.19

1.5

1.6

—

(3025159) Blasts/100 leukocytes in Blood

0.76

0.17

2.6

4.3

—

0.50

—

(4200892) Spirometry reversibility

1.14

0.16

1.3

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.17

0.16

2.4

3.5

—

(36660697) Celiac disease serology panel - Serum

1.17

0.16

1.3

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

308

1.11

0.13

3.3

4.1

26.49

44.39

ng/l

0.46

206

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.17

0.10

1.4

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1.12

0.10

2.8

1.6

—

(3009343) pH of Capillary blood

1.07

0.09

1.6

3.2

—

7.46

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.08

0.09

1.7

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.04

0.08

2.2

1.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1.04

0.08

2.8

1.9

61.18

67.32

g/l

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.81

0.08

1.4

1.5

—

(3022621) pH of Urine by Test strip

1.05

0.08

2.0

2.3

—

(3013512) EKG study

234

0.92

0.07

3.7

3.9

—

(1761868) Lipid panel - Serum or Plasma

288

1.06

0.05

3.8

2.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

247

1.02

0.00

4.7

3.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

181

0.99

0.00

1.6

1.3

2.55

2.51

g/l

0.02

101

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.90

0.00

1.1

1.5

—

(3019225) pH of Specimen

0.94

0.00

2.0

4.5

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

-0.00

0.0

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

5.8

—

0.66

—

(3022145) Colonoscopy Study observation

0.98

-0.00

1.2

1.3

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

-0.00

0.0

1.0

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

4.7

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

-0.00

0.0

1.3

—

38.33

—

(3044927) Protein electrophoresis panel - Urine

0.00

-0.00

0.0

1.1

—

(3028433) Virus identified in Specimen by Culture

0.00

-0.00

0.0

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.8

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

9.2

—

999.20

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.94

-0.00

1.3

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

-0.00

0.0

10.2

—

(3038026) Centromere Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

-0.00

0.0

1.0

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

3.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.00

-0.00

0.0

1.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

3.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

669.60

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

10.8

—

1610.40

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

3.7

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

69.20

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.02

-0.00

1.7

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

1.68

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(4281824) Cell count and differential, peritoneal fluid

0.00

-0.00

0.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

-0.00

0.0

1.8

—

(3017569) Oxygen content in Arterial blood

0.00

-0.00

0.0

1.6

—

(3024263) Appearance of Synovial fluid

0.00

-0.00

0.0

1.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.0

—

146.20

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

111.00

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_CONNSOFT_ABD and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_CONNSOFT_ABD	1.671 [1.13, 2.47]	0.01
Birth year	0.997 [0.99, 1.01]	0.464

During the follow-up period (1.1.1998 — 31.12.2019), 55 out of 382 females with CD2_BENIGN_CONNSOFT_ABD died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_CONNSOFT_ABD.

N-year risk	Females	Males
1	0.156%	No data
5	1.052%	No data
10	2.632%	No data
15	4.982%	No data
20	8.626%	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_CONNSOFT_ABD – Benign neoplasm: Connective and other soft tissue of abdomen

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Connective and other soft tissue of abdomen

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints